camptothecin has been researched along with Liposarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allonca, E; Astudillo, A; Fernandez-Garcia, MT; Garcia-Pedrero, JM; Martinez-Cruzado, L; Rodriguez, A; Rodriguez, R; Santos, L; Tornin, J | 1 |
1 other study(ies) available for camptothecin and Liposarcoma
Article | Year |
---|---|
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Cycle Checkpoints; Cell Proliferation; Dioxoles; DNA Damage; Drug Synergism; Humans; Liposarcoma; Liposarcoma, Myxoid; Mice; Neoplastic Stem Cells; Signal Transduction; Tetrahydroisoquinolines; Trabectedin; Xenograft Model Antitumor Assays | 2017 |